Brainstorm Cell Therapeutics reported $-5360000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Biogen BIIB:US $ 903.4M 316.6M
Brainstorm Cell Therapeutics BCLI:US $ -5.36M 1.83M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cytokinetics CYTK:US $ -86.75M 56.18M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M